Once Weekly Dulaglutide Cardiovascular protection and Glycemic Control for T2D

Introduction

Take This Event

The discussion will cover several aspects of Cardiovascular protection and Glycemic Control of Once Weekly Dulaglutide

Objectives

1- HCPs to understand different cardiovascular trials design and patient population distribution.
2- Understand the difference between primary and secondary CV protection.
3- Understand the results of recent CV trials for Once-weekly dulaglutide and its implications on T2D patients.

See Registration Policies, Cancellations & Refunds